Molecularly severe roX1 mutations contribute to dosage compensation in Drosophila

Genesis. 2009 Jan;47(1):49-54. doi: 10.1002/dvg.20463.

Abstract

Drosophila melanogaster males maintain a constant ratio of X-linked to autosomal gene products by increasing expression from their single X chromosome. This is achieved through the action of a complex composed of protein and roX RNA. This complex binds in the body of genes and increases expression through chromatin modification. The X-linked roX genes produce RNAs that are essential but redundant for recognition and modification of the male X chromosome. We report that some molecularly severe roX1 mutations with no detectable transcript accumulation contribute dramatically to male rescue by autosomal roX1 transgenes. We propose that this represents genetic complementation between a source of roX RNA (the autosomal transgene) and the severely mutated X-linked allele.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Dosage Compensation, Genetic / genetics*
  • Drosophila Proteins / genetics*
  • Drosophila melanogaster / genetics*
  • Drosophila melanogaster / metabolism
  • Gene Dosage
  • Male
  • Mutation / genetics*
  • Transcription Factors / genetics*
  • Transcription, Genetic / genetics
  • Transgenes / genetics

Substances

  • Drosophila Proteins
  • Transcription Factors
  • roX1 protein, Drosophila